STEPHENE GWINN: Open Payments
NPI 1285382606 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 25 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $199 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| PFIZER INC. | 4 | $83 |
| Endo USA, Inc. | 3 | $66 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $40 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| TOLMAR, INC. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $29 |
| UROGEN PHARMA, INC. | 1 | $22 |
| Laborie Medical Technologies Corp. | 1 | $18 |
Products named: RYBREVANT, XTANDI, AVEED, ORGOVYX, ERLEADA, PYLARIFY, PROVENGE, JATENZO.
Industry payments across TX — which companies pay providers there.
